Unknown

Dataset Information

0

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers.


ABSTRACT: Recombinant vesicular stomatitis virus (VSV)-fusion and hemagglutinin (FH) was developed by substituting the promiscuous VSV-G glycoprotein (G) gene in the backbone of VSV with genes encoding for the measles virus envelope proteins F and H. Hybrid VSV-FH exhibited a multifaceted mechanism of cancer-cell killing and improved neurotolerability over parental VSV in preclinical studies. In this study, we evaluated VSV-FH in vitro and in vivo in models of hepatobiliary and pancreatic cancers. Our results indicate that high intrahepatic doses of VSV-FH did not result in any significant toxicity and were well tolerated by transgenic mice expressing the measles virus receptor CD46. Furthermore, a single intratumoral treatment with VSV-FH yielded improved survival and complete tumor regressions in a proportion of mice in the Hep3B hepatocellular carcinoma model but not in mice xenografted with BxPC-3 pancreatic cancer cells. Our preliminary findings indicate that VSV-FH can induce potent oncolysis in hepatocellular and pancreatic cancer cell lines with concordant results in vivo in hepatocellular cancer and discordant in pancreatic cancer without the VSV-mediated toxic effects previously observed in laboratory animals. Further study of VSV-FH as an oncolytic virotherapy is warranted in hepatocellular carcinoma and pancreatic cancer to understand broader applicability and mechanisms of sensitivity and resistance.

SUBMITTER: Nagalo BM 

PROVIDER: S-EPMC7437509 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3946955 | biostudies-literature
| S-EPMC7963195 | biostudies-literature
| S-EPMC3959227 | biostudies-literature
| S-EPMC5308675 | biostudies-literature
| S-EPMC10537684 | biostudies-literature
| S-EPMC5483446 | biostudies-literature
| S-EPMC8703189 | biostudies-literature
| S-EPMC3544977 | biostudies-literature
| S-EPMC3838279 | biostudies-other
| PRJNA508804 | ENA